LGC Biosearch Technologies A/S: Financial statements 2023
CVR: 34884900
Source: annual report 2023, Danish Business Authority
01/04/2022 – 31/03/2023
LGC Biosearch Technologies A/S (CVR 34884900) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 118,026,229 and a net result of DKK 11,733,695 compared with DKK 12,605,086 the year before. That is an increase of 16.3% compared with the year before. The profit margin was 9.9%. Equity in the 2023 report amounted to DKK 77,314,694. The solvency ratio was 74.8%. The company had 29 employees in the financial year.
- Revenue
- DKK 118,026,229
- Gross Profit
- DKK 60,052,748
- Profit/Loss
- DKK 11,733,695
- Equity
- DKK 77,314,694
- Total Assets
- DKK 103,375,139
- Employees
- 29
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 118M | 60.1M | 11.7M | 77.3M | 29 |
| 2022 | 101.5M | 50.5M | 12.6M | 65.6M | 22 |
| 2021 | 103.8M | 70.9M | 35.6M | 53M | 29 |
| 2020 | 41.8M | 23.2M | 8M | 17.4M | 22 |
| 2019 | - | 15.8M | 3.8M | 9.3M | 19 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of July 7, 2023, KPMG P/S has been appointed auditor of LGC Biosearch Technologies A/S.
As of July 7, 2023, EY Godkendt Revisionspartnerselskab has stepped down as auditor of LGC Biosearch Technologies A/S.
As of February 1, 2023, Henrik Daugård has joined the board of directors of LGC Biosearch Technologies A/S.
As of February 1, 2023, Jakob Thielke Karaffa has left the board of directors of LGC Biosearch Technologies A/S.
About LGC Biosearch Technologies A/S
LGC Biosearch Technologies A/S is a Danish company of the type Aktieselskab based in Lystrup, founded in 2012. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named DNA TECHNOLOGY A/S and BIOSEARCH TECHNOLOGIES DENMARK A/S. The management consists of Daren Dick. The board consists of Henrik Daugård (chair), Bettina Kecskes and Daren Dick. The company is owned by Biosearch Technologies, Inc.. The company has 47 employees (2026). In 2026, the company reported revenue of DKK 106,677,751 and a net result of DKK 8,198,725 compared with DKK 11,805,577 the year before. Equity in the 2026 report amounted to DKK 88,072,722.